Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Hold it Baby...

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Jan 08, 2021 4:02pm

139 Views

Post# 32256402

RE:RE:RE:RE:Hold it Baby...

Oh yeah...I think we did it. Thank you who ever trumped the Cheeto lovers! Yeeessss.....Enjoy your weekend with a smile and good glass of wine!

Wino115 wrote: Are you kidding me! I bet a Cheeto lover told his desk to sell 1 share. I demand a recount, it was taken from me!

Wino115 wrote: Hold you mothertrucker! Someone click that buy at 3:59. We deserve a happy weekend for once.

Wino115 wrote:
We broke $3, I would love to see it put the $2 handle in our rear view mirror for good! Please Hold Baby!

Wino115 wrote: I would love to see it hold a US$3 handle today for once. It's been 2 years of not being able to hold breakouts. I have been consistent in saying they need to have true value-enhancing developments that should lead to concrete and incontrovertible market cap support. We're seeing a bit of it today and beginning to walk down those paths. The biggest supports are still to come. But if we can eliminate the "downside" that it's worth $2 something and slowly narrow the future value focus into view at higher levels, we may be on that path of gaining some share price momentum back in to it which all the portfolio managers younger than 50 want to see before they buy. Let's hold that $3 level today!!